Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artemisia annua leaf is the dried or fresh foliage of the Artemisia annua plant. It has been used for over 2,000 years in traditional Chinese medicine to treat fevers and malaria[1][3][5]. The primary active compound is artemisinin—a sesquiterpene lactone with a characteristic peroxide bridge—responsible for its potent antimalarial effects[6]. Artemisinin acts by generating free radicals that damage malaria parasites (Plasmodium species) through cleavage of its endoperoxide bond[3]. The whole leaf contains additional compounds such as flavonoids and terpenes that may enhance bioavailability and efficacy compared to isolated artemisinin[5]. Beyond malaria, extracts have shown anti-inflammatory, antimicrobial, antiviral and anticancer activities in preclinical studies; however clinical evidence outside malaria remains limited[2][4][8]. Dried-leaf preparations are available as dietary supplements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artemisia annua leaf.